For the second year in a row, Safeway has received a perfect score of 100% on the Corporate Equality Index, a national benchmarking survey and report on corporate policies and practices pertinent to LGBT equality, administered by the Human Rights Campaign Foundation.
Stop & Shop is reminding shoppers that it is not too late to get a flu shot.
Maesa — which designs, develops and manufactures private label and exclusive brands for retailers, as well as packaging and turnkey products for beauty brands — has appointed industry vet Shawn Haynes to the newly created position of SVP of sales, mass and drugstore retailers.
The Food and Drug Administration granted accelerated approval to Lynparza (olaparib), a new drug treatment for women with advanced ovarian cancer associated with defective BRCA genes, as detected by an FDA-approved test.
Prestige lip color sales in the United States experienced a 24% increase in dollar sales during the month of November as the bold lip trend shows little signs of fading, according to global information company, The NPD Group.
Twelve holiday health hazards, provided by Vitals.
Estée Lauder has signed an agreement to acquire Glamglow, a skin care brand focused on treatment masks. Terms of the deal were not disclosed. The acquisition is expected to close in January 2015.
The Food and Drug Administration has approved Zerbaxa (ceftolozane/tazobactam), a new antibacterial drug product, to treat adults with complicated intra-abdominal infections and complicated urinary tract infections.
The Food and Drug Administration has approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis.
Sandoz has announced the U.S. market introduction of estradiol transdermal system, an authorized generic version of Vivelle-Dot, which is marketed by Novartis Pharmaceuticals.